Plain-English translation of NCT03003572 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for a new way to measure how active your Sjögren's syndrome is at any given time. Researchers will take a blood sample from you and test it for a specific antibody called anti-Ro/SSA IgE, which may help doctors understand whether your disease is flaring up or stable. This simple blood test could become a routine way for doctors to track your condition more accurately.
Sjögren's syndrome is unpredictable—it comes and goes in flares, and doctors currently don't have a reliable, easy-to-use test to tell when the disease is actively getting worse. Finding a better biomarker could help doctors catch flares earlier and adjust your treatment before symptoms become severe.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have one blood sample taken at a single visit. The researchers will test your blood for the anti-Ro/SSA IgE antibody and collect information about your Sjögren's symptoms and disease activity using standard questionnaires. That's the main requirement—no long-term visits or ongoing medication needed.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France